Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dfc0b033ac4c841466d97a5f28ea32b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate |
1987-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a231c143931ea740b35cadf67a06bce1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc95fb38745d7c4b4c638fe6ac35c5dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36110d3dd9c00ad88cb87f5bea5c3775 |
publicationDate |
1989-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-S6485-A |
titleOfInvention |
Novel cephalosporin derivative |
abstract |
NEW MATERIAL:A compound expressed by formula I (R represents vinyl, phenyl or aralkyl which may have a substituent group), salt or hydrolyzable ester thereof. n EXAMPLE: 7-[2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-vinyloxyimino)acetamide]-3-(1- carboxymethylpyridinio-4-yl)thiomethyl-4-carboxylate. n USE: An antibacterial agent, especially useful for treating human microbisms with Gram-negative bacteria containing especially glucose-nonfermenting Gram- negative bacilli as prophlogstic bacteria. n PREPARATION: A compound (salt) expressed by formula II (R 1 is same as R; R 2 represents H or carboxyl-protecting group; R 3 represents H or amino- protecting group; X represents leaving group) is reacted with a compound expressed by formula III (R 4 is same as R 2 ) to form a compound expressed by formula IV, as necessary, followed by elimination of protecting groups. n COPYRIGHT: (C)1989,JPO&Japio |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4950177-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5407930-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5403835-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100926184-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9107410-A1 |
priorityDate |
1986-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |